BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 38726585)

  • 1. Clostridioides Difficile: A Concise Review of Best Practices and Updates.
    Yakout A; Bi Y; Harris DM
    J Prim Care Community Health; 2024; 15():21501319241249645. PubMed ID: 38726585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    Bishop EJ; Tiruvoipati R
    J Antimicrob Chemother; 2022 Dec; 78(1):21-30. PubMed ID: 36441203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating changes in
    Durham SH; Le P; Cassano AT
    J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutics for
    Khanna S; Voth E
    Expert Rev Gastroenterol Hepatol; 2023; 17(9):903-911. PubMed ID: 37606962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: The epidemiology and management of Clostridioides difficile infection-A clinical update.
    Clarke LM; Allegretti JR
    Aliment Pharmacol Ther; 2024 Jun; 59(11):1335-1349. PubMed ID: 38534216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
    Gentry CA; Campbell DL; Williams RJ
    Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
    van Prehn J; Reigadas E; Vogelzang EH; Bouza E; Hristea A; Guery B; Krutova M; Norén T; Allerberger F; Coia JE; Goorhuis A; van Rossen TM; Ooijevaar RE; Burns K; Scharvik Olesen BR; Tschudin-Sutter S; Wilcox MH; Vehreschild MJGT; Fitzpatrick F; Kuijper EJ;
    Clin Microbiol Infect; 2021 Dec; 27 Suppl 2():S1-S21. PubMed ID: 34678515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of
    Oksi J; Anttila VJ; Mattila E
    Ann Med; 2020; 52(1-2):12-20. PubMed ID: 31801387
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic Therapies for Clostridioides difficile Infection in Children.
    Gonzales-Luna AJ; Carlson TJ; Garey KW
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S52-S57. PubMed ID: 34791393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Clostridioides difficile Infection: Diagnosis, Treatment, and Future Perspectives.
    Cymbal M; Chatterjee A; Baggott B; Auron M
    Am J Med; 2024 Jul; 137(7):571-576. PubMed ID: 38508330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines.
    Rajasingham R; Enns EA; Khoruts A; Vaughn BP
    Clin Infect Dis; 2020 Feb; 70(5):754-762. PubMed ID: 31001619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
    Collins DA; Riley TV
    Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes: a systematic review and meta-analysis.
    Stabholz Y; Paul M
    Clin Microbiol Infect; 2024 Jan; 30(1):51-58. PubMed ID: 37690610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edges in Clostridioides difficile infections.
    Durovic A; Tschudin-Sutter S
    Swiss Med Wkly; 2021 Sep; 151():w30033. PubMed ID: 34652093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in the Prevention and Treatment of
    Bainum TB; Reveles KR; Hall RG; Cornell K; Alvarez CA
    Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838352
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Mullish BH; Williams HR
    Clin Med (Lond); 2018 Jun; 18(3):237-241. PubMed ID: 29858434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fidaxomicin for the treatment of
    Skinner AM; Scardina T; Kociolek LK
    Future Microbiol; 2020 Jul; 15(11):967-979. PubMed ID: 32715754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of
    Deac IŞ; Ofrim AM; Fărcaş RA; Grad S; Popa ŞL; Dumitraşcu DL
    Med Pharm Rep; 2024 Jan; 97(1):5-11. PubMed ID: 38344334
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
    Nelson RL; Suda KJ; Evans CT
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004610. PubMed ID: 28257555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clostridioides difficile - New Insights and Therapy Recommendations].
    Schönherr S; Jung L; Lübbert C
    Dtsch Med Wochenschr; 2023 Jun; 148(12):752-758. PubMed ID: 37257477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.